ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE

This adverse event was reported 13 times

ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 1 0.0055
1 GONADOTROPHIN, CHORIONIC 1 0.0016
2 GOLIMUMAB 1 0.0001
3 ERGOCALCIFEROL 1 0.0000
4 NINTEDANIB 1 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 5 0.0000
6 CYCLOPHOSPHAMIDE 5 0.0000
7 TACROLIMUS OINTMENT 0.1% 3 0.0000
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 3 0.0000
9 TACROLIMUS 3 0.0000
See all drugs enriched for association with ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE